Viking Therapeutics (VKTX) Stock: Buy, Sell, or Hold?
VKTX - Viking Therapeutics, Inc
$25.83
-0.55 (-2.08%)
▼
5d:
-5.63%
30d:
-37.98%
90d:
-25.75%
HOLD
LOW Confidence
Analysis Updated: Oct 22, 2026 12:00 AM ET
Earnings: Oct 28, 2026
5d
Get Alerted When VKTX Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: VKTX shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
📊 HOLD: VKTX shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
In-depth Analysis How we analyze
Valuation Analysis: VKTX is currently trading at $25.83, which is considered oversold relative to its 30-day fair value range of $25.92 to $34.19.
Technical Outlook: Technically, VKTX is in a downtrend. Immediate support is located at $24.94, while resistance sits at $28.86.
Market Sentiment: VKTX scores 75/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. Wall Street analysts see significant upside, with an average price target of $94.10 (+256.7%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, VKTX is in a downtrend. Immediate support is located at $24.94, while resistance sits at $28.86.
Market Sentiment: VKTX scores 75/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. Wall Street analysts see significant upside, with an average price target of $94.10 (+256.7%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$25.92 -
$34.19
Company Quality Score
59/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
94.7%
All Signals
- BULLISH: Price oversold vs 30-day range
- BULLISH: Strong technical setup (75/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 256.7% below Wall St target ($94.10)
- CAUTION: Bottoming setup, but lagging the sector by 17% over 20 days — wait for relative strength
- CAUTION: 5-day price weakness (-5.6%) - monitor closely
Trading Range Analysis
30-Day Trading Range
$25.92 -
$34.19
Current vs Trading Range
OVERSOLD
Support & Resistance Levels
Support Level
$24.94
Resistance Level
$28.86
Current Trend
Downtrend
Technical data as of
Oct 22, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-6.07
Wall Street Target
$94.10
(+256.7%)
Share & Embed Analysis
Last updated: October 22, 2026 4:13 PM ET
Data refreshes hourly during market hours. Next update: 5:13 PM
Data refreshes hourly during market hours. Next update: 5:13 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is VKTX showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
DNLI
Denali Therapeutics Inc |
STRONG BUY
20 analysts |
$36 | 68 BUY |
|
SRRK
Scholar Rock Holding Corp |
STRONG BUY
18 analysts |
$70 | 71 BUY |
|
WVE
Wave Life Sciences Ltd |
STRONG BUY
20 analysts |
$17 | 60 HOLD |
|
MIRM
Mirum Pharmaceuticals Inc |
STRONG BUY
14 analysts |
$153 | 68 BUY |
|
PTGX
Protagonist Therapeutics… |
STRONG BUY
14 analysts |
$178 | 64 BUY |
